Activation and lysis of human CD4 cells latently infected with HIV-1
about
Elimination of HIV-1-infected cells by broadly neutralizing antibodiesHighlights from the Seventh International Workshop on HIV Persistence during Therapy, 8-11 December 2015, Miami, Florida, USALatency reversal and viral clearance to cure HIV-1.Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune SystemHumoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV InfectionNeutralizing Monoclonal Antibodies to Fight HIV-1: On the Threshold of Success.Strategies to target non-T-cell HIV reservoirsBispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency.HIV-1 Latency and Eradication: Past, Present and FutureInternational AIDS Society global scientific strategy: towards an HIV cure 2016.Landscape review of current HIV 'kick and kill' cure research - some kicking, not enough killing.Engineering broadly neutralizing antibodies for HIV prevention and therapy.Use of broadly neutralizing antibodies for HIV-1 prevention.Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infectionBispecific antibodies for viral immunotherapy.HIV antibodies for treatment of HIV infection.Novel AIDS therapies based on gene editing.Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size.One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected Cells.HDAC inhibition induces HIV-1 protein and enables immune-based clearance following latency reversal.Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies.HIV: Cure by killing.Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques.Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics.The Antiviral Immune Response and Its Impact on the HIV-1 Reservoir.Immune Interventions to Eliminate the HIV Reservoir.The B-Cell Follicle in HIV Infection: Barrier to a Cure.Antiviral Activity of HIV gp120 Targeting Bispecific T Cell Engager (BiTE®) Antibody Constructs.Accumulation of follicular CD8+ T cells in pathogenic SIV infection.Antibodies and Antibody Derivatives: New Partners in HIV Eradication Strategies
P2860
Q27329126-816976AC-2CEF-4968-9033-7A6676CE0C1BQ28384231-502BE244-B5E0-4826-8864-C766415616B9Q30248766-D43369BA-1E8E-4316-93C8-87FDA87BA17EQ33592852-68D8C03E-A1A8-4334-99AE-38ED016BFCC0Q33620546-CA8A2798-E2E0-4B85-A976-899A72619B61Q34550046-D6DC790E-8AF9-4979-BEFE-12B476B20FE0Q37099969-95A60273-7CFA-4DCB-90B4-FF66755F1C4CQ37145901-5F2ED50F-00AE-4912-AD1D-64716FB4C48EQ37505823-B48B576F-EF37-44E5-92B1-9F752E08E032Q37661770-76B81A66-C9A2-4119-AFC1-B66DCF5AA6FCQ38636019-E18C018E-55D3-4F72-8A15-581B67FE68AEQ38717198-79FD9B9D-80C7-4D18-80BA-AA448F0CDFBAQ38764543-C6F59DFB-4DD8-41D7-A8CF-B5CE0C958F01Q38977425-550A29FD-AC07-4B1A-B2DB-BBEA92C4F74AQ38992408-E951A51C-F55C-40C3-B2C0-71762460C676Q39108716-74B0F02B-9EFC-4516-B771-D783D004DF63Q39140209-376BFC81-6B16-4FDF-8EB8-74C271A9DD1CQ39599213-308C034D-89E7-470A-B26E-C69F9216FEF1Q40074629-6DE0FA26-CABB-4A11-AD04-03D8D1B648D4Q40080802-B47E934A-213A-47D4-AE74-5484AFF06FEAQ40366328-264AFC52-22AE-4B7F-8A14-370ACC4CE72CQ40884150-4CD7D3C1-00E4-4A49-931A-0F30E77F360FQ41933491-F38265CF-5B11-4BD1-B1BD-7719071F77B7Q47110966-A52A6936-6A13-4736-86CE-5A3A5D7728A9Q47570404-68AFDCE5-8A8A-41BA-8F35-21D2351AB84FQ47600020-64FFD0FA-93E0-401F-914C-63A60B1649DFQ47600062-7E814450-36E7-46CE-BBE8-161944071301Q48505361-18D39D53-8766-4796-8B45-90AE2E92B0FEQ54222576-38753F5A-0A2E-44B9-9077-47E676ADA37AQ54234277-2999CA29-BCC5-4EE3-83B5-F07E9360D0B1Q58572618-AE1C2085-230A-489A-9575-75B844D7D973
P2860
Activation and lysis of human CD4 cells latently infected with HIV-1
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Activation and lysis of human CD4 cells latently infected with HIV-1
@ast
Activation and lysis of human CD4 cells latently infected with HIV-1
@en
type
label
Activation and lysis of human CD4 cells latently infected with HIV-1
@ast
Activation and lysis of human CD4 cells latently infected with HIV-1
@en
prefLabel
Activation and lysis of human CD4 cells latently infected with HIV-1
@ast
Activation and lysis of human CD4 cells latently infected with HIV-1
@en
P2093
P2860
P50
P356
P1476
Activation and lysis of human CD4 cells latently infected with HIV-1
@en
P2093
Ivelin Georgiev
Jason Hataye
John-Paul Todd
Joseph P Casazza
Keyun Wang
Peter D Kwong
Richard A Koup
Sijy O'Dell
Srinivas S Rao
P2860
P2888
P356
10.1038/NCOMMS9447
P407
P577
2015-10-20T00:00:00Z
P5875
P6179
1039028053